PureTech Health PLC Holding(s) in Company (9286E)
July 22 2016 - 2:00AM
UK Regulatory
TIDMPRTC
RNS Number : 9286E
PureTech Health PLC
22 July 2016
For filings with the FCA include the
annex
For filings with issuer exclude the
annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
----------------------------------------------------
1. Identity of the issuer or PureTech Health Plc
the underlying issuer of existing
shares to which voting rights
are attached:(ii)
----------------------------------------------------------- --------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
---------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
---------------------------------------------------------------- ---------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
---------------------------------------------------------------- ---------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
---------------------------------------------------------------- ---------------------
An event changing the breakdown of voting rights
---------------------------------------------------------------- ---------------------
Other (please
specify):
---------------------------------------------------------- ---- ---------------------
3. Full name of person(s) Baillie Gifford & Co
subject to the
notification obligation:(iii)
----------------------------------------------------------- --------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
----------------------------------------------------------- --------------------------
5. Date of the transaction 20 July 2016
and date on
which the threshold is
crossed or
reached:(v)
----------------------------------------------------------- --------------------------
6. Date on which issuer 21 July 2016
notified:
----------------------------------------------------------- --------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 5%
----------------------------------------------------------- --------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
-------------- ------------------------------ ----------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
-------------- -------------- -------------- ------------- ---------------------- -------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
-------------- ------------ ------------ ------------- --------- ----------- -------- ---------
Ordinary
Share
GB00BY2Z0H74 12,529,837 5.28%
----------- -------- ---------
Below Below
5% 5%
-------------- -------------- ------------------------------------ ----------- -------- ---------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
---------------- ------------- ----------------------------- --------------------- -------------------
N/A
---------------- ------------- ----------------------------- --------------------- -------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- ------------- ------------- -------------- ---------------------- -------------------
N/A Nominal Delta
--------------- ------------- ------------- -------------- ---------------------- -------- ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
----------------------------------------------- ---------------------------------------------------------
12,529,837 5.28%
----------------------------------------------- ---------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-------------------------------------------------------------------------
In the narrative below, the figures in [ ] indicate
the amount of voting rights and the percentage held
by each controlled undertaking where relevant.
Baillie Gifford & Co, a discretionary investment manager,
is the parent undertaking of an investment management
group.
Its wholly-owned subsidiary undertaking Baillie Gifford
Overseas Limited [3,421,563:1.44%] is also a discretionary
investment manager.
Its wholly-owned subsidiary undertaking Baillie Gifford
& Co Limited [4,011,350:1.69%] is an OEIC Authorised
Corporate Director and Unit Trust Manager which has
delegated its discretionary investment management role
to Baillie Gifford & Co.
Its wholly-owned subsidiary undertaking Baillie Gifford
Life Limited [1,697,490:0.72%] is a life assurance company
which procures discretionary investment management services
from Baillie Gifford & Co in respect of its own account
shareholdings.
Proxy Voting:
-------------------------------------------------------------------------
10. Name of the proxy holder: N/A
--------------------------------------------------------- --------------
11. Number of voting rights proxy
holder will cease to hold:
--------------------------------------------------------- --------------
12. Date on which proxy holder will
cease to hold voting rights:
--------------------------------------------------------- --------------
13. Additional information:
--------------------------------------------------------- --------------
14. Contact name: Mike Bassi
--------------------------------------------------------- --------------
15. Contact telephone number: 0131 275 3852
--------------------------------------------------------- --------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLRBMBTMBJTTAF
(END) Dow Jones Newswires
July 22, 2016 02:00 ET (06:00 GMT)
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jul 2023 to Jul 2024
